León ACE, Arteaga MMP, Iglesias LJ, Bernárdez ZI

Language: Spanish
References: 13
Page: 61-63
PDF size: 113.48 Kb.

ABSTRACT

Objective: Knowing the answer to the treatment with sildenafil of infants with pulmonary hypertension in children.
Material and methods: 88 neonates response with pulmonary hypertension who were treated with sildenafil at 0.5 to 3 mg/kg/dose was studied.
Results: Independent of the severity of the pulmonary hypertension, the doses of sildenafil used was 1 mg/kg dose every six hours.
Conclusions: The findings showed that sildenafil is effective in the management of pulmonary hypertension in infants, both in the short, medium or long term and well tolerated, although not established optimal dose in this disease.

REFERENCES

1. Wert SE. Trastornos respiratorios agudos. En: Avery GB, Fletcher MA, MacDonald MG. Neonatología. Fisiopatología y manejo del recién nacido. 5 ed. Ed. Médica Panamericana, Buenos Aires. 2001: 485-510.

2. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension, a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009; 53: 1573-1619.

3. Stoll BJ, Kliegman RM. Enfermedades del aparato respiratorio. En: Behrman RE, Kliegman RM, Jenson HB. Nelson Tratado de Pediatría. 17 ed. Ed. Elsevier, Madrid: 2004, pp. 573-579.

4. Victoria OG, Mojarro RJ, Alva EC, Villasis KM, Labarthe CJ, Arellano PM et al. Ecocardiografía Doppler en recién nacidos con riesgo de hipertensión arterial pulmonar. Rev Mex Cardiol. 1996; 7(1): 25-31.

5. Grippo M, Kreutzer C, Sardella A. Hipertensión pulmonar. En: Macri CN, Teper AM. Enfermedades Respiratorias Pediátricas. Ed.

6. McGraw-Hill/Interamericana, México. 2003, pp. 549-561.

7. Martínez BJP, Castañón LL, Iglesias AE, Fernández CF, García AML, San Martín SL et al. Tratamiento con óxido nítrico inhalado en hipoxemia neonatal. Bol Pediatr. 2000; 40: 3-7.

8. García ME, Ibarra RI, Pérez NJL, Tejero MI, Espósito MJF, Suárez LJ et al. Sildenafilo en el tratamiento de la hipertensión pulmonar. An Esp Pediatr. 2003; 59(1): 110-113.

9. Baquero H, Neira F, Venegas V, Sola A, Soliz A. Oral sildenafil for infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics. 2006; 117(4): 1077-1083.

10. Sola A. Patologías con hipoflujo pulmonar. En: Sola A, Rogido M. Cuidados especiales del feto y recién nacido. Buenos Aires: Científica Interamericana, 2001: 995-1023.

11. Michelakis E, Tymchak W, Lien D, Webster L, Hashimoto K, Archer S. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation. 2002; 105(20): 2398-2403.

12. Díaz CR. Hipertensión pulmonar en niños. En: Reyes MA, Aristizábal Duque G, Leal Quevedo FJ. Neumología pediátrica. 4 ed. Colombia: Médica Internacional, 2001, pp. 525-36.

13. Itoh T, Nagaya N, Fujii T, Iwase T, Nakanishi N, Hamada K, Kangawa K, Kimura H. A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats. Am J Respir Crit Care Med. 2004; 169(1): 34-38.